Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy

Extramammary Paget disease (EMPD) is a locally aggressive cutaneous malignancy that usually arises in anogenital or axillary skin. Immune checkpoint inhibitors targeting programmed cell death receptor (PD-1) and/or its ligand (PD-L1) are approved for the treatment of several types of cancer, and res...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauzo, Shakuntala H., Tetzlaff, Michael T., Milton, Denái R., Siroy, Alan E., Nagarajan, Priyadharsini, Torres-Cabala, Carlos A., Ivan, Doina, Curry, Jonathan L., Hudgens, Courtney W., Wargo, Jennifer A., Sahin, Aysegul A., Pettaway, Curtis A., Prieto, Victor G., Aung, Phyu P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627796/
https://www.ncbi.nlm.nih.gov/pubmed/31146499
http://dx.doi.org/10.3390/cancers11060754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627796/
https://www.ncbi.nlm.nih.gov/pubmed/31146499
http://dx.doi.org/10.3390/cancers11060754

Ejemplares similares